Stroke Mortality Variations in South-East Asia: Empirical Evidence from the Field

Hoy, Damian; Rao, Chalapati; Hoa, Nguyen Phuong; Suhardi, S; Lwin, Aye Moe Moe

doi:10.1111/j.1747-4949.2012.00903.x

Cited by 32 publications

(25 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…26 This study, however, may have limited generalizability because stroke rates may be higher among Asian populations. 27–29 In a large single-center study of 2,384 hemodialysis patients in the United Kingdom, the incident stroke rate was 15 per 1000 patient years, an incidence similar to that seem in the Taiwan study, with major risk factors including diabetes and hypertension. There was a 24% incidence of mortality at 1 year after an acute stroke in this study, which was similar to that seen in the general population.…”

Section: Chronic Kidney Disease and Strokementioning

confidence: 61%

Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages

Dad

Weiner

2015

Seminars in Nephrology

View full text Add to dashboard Cite

Summary Cerebrovascular disease and stroke are very common at all stages of chronic kidney disease (CKD), likely representing both shared risk factors as well as synergy among risk factors. More subtle ischemic brain lesions may be particularly common in the CKD population, with subtle manifestations including cognitive impairment. For individuals with nondialysis CKD, the prevention, approach to, diagnosis, and management of stroke is similar to the general, non-CKD population. For individuals with end-stage renal disease, far less is known regarding the prevention of stroke. Stroke prophylaxis using warfarin in dialysis patients with atrial fibrillation in particular remains of uncertain benefit. End-stage renal disease patients can be managed aggressively in the setting of acute stroke. Outcomes after stroke at all stages of CKD are poor, and improving these outcomes should be the subject of future clinical trials.

show abstract

Section: Chronic Kidney Disease and Strokementioning

confidence: 61%

Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages

Dad

Weiner

2015

Seminars in Nephrology

View full text Add to dashboard Cite

show abstract

“…A recent update of the IDF Diabetes Atlas attributes 386,400 deaths to diabetes in Indonesia in 2013 [116]. Stroke is the leading cause of death with rates of over 300/100,000 [82]. One study provides estimates of lung cancer deaths, which exceed the WHO estimates by 1.24 times, presenting a crude lung cancer mortality rate of 17.6 per 226,063 people [45].…”

Section: Resultsmentioning

confidence: 99%

How is Indonesia coping with its epidemic of chronic noncommunicable diseases? A systematic review with meta-analysis

et al. 2017

View full text Add to dashboard Cite

BackgroundChronic noncommunicable diseases (NCDs) have emerged as a huge global health problem in low- and middle-income countries. The magnitude of the rise of NCDs is particularly visible in Southeast Asia where limited resources have been used to address this rising epidemic, as in the case of Indonesia. Robust evidence to measure growing NCD-related burdens at national and local levels and to aid national discussion on social determinants of health and intra-country inequalities is needed. The aim of this review is (i) to illustrate the burden of risk factors, morbidity, disability, and mortality related to NCDs; (ii) to identify existing policy and community interventions, including disease prevention and management strategies; and (iii) to investigate how and why an inequitable distribution of this burden can be explained in terms of the social determinants of health.MethodsOur review followed the PRISMA guidelines for identifying, screening, and checking the eligibility and quality of relevant literature. We systematically searched electronic databases and gray literature for English- and Indonesian-language studies published between Jan 1, 2000 and October 1, 2015. We synthesized included studies in the form of a narrative synthesis and where possible meta-analyzed their data.ResultsOn the basis of deductive qualitative content analysis, 130 included citations were grouped into seven topic areas: risk factors; morbidity; disability; mortality; disease management; interventions and prevention; and social determinants of health. A quantitative synthesis meta-analyzed a subset of studies related to the risk factors smoking, obesity, and hypertension.ConclusionsOur findings echo the urgent need to expand routine risk factor surveillance and outcome monitoring and to integrate these into one national health information system. There is a stringent necessity to reorient and enhance health system responses to offer effective, realistic, and affordable ways to prevent and control NCDs through cost-effective interventions and a more structured approach to the delivery of high-quality primary care and equitable prevention and treatment strategies. Research on social determinants of health and policy-relevant research need to be expanded and strengthened to the extent that a reduction of the total NCD burden and inequalities therein should be treated as related and mutually reinforcing priorities.

show abstract

“…With this in mind, and as BoD research endeavors to incorporate all conditions of public health importance, it is often necessary to predict estimates using models, which are built up from various covariates (6,7,21). Although this ensures an estimate for all causes within a region, these modeled estimates have limitations (22). In PICTs, the greatest limitation is the paucity of data that have been analyzed, synthesized, and made publically available.…”

Section: Potential Limitationsmentioning

confidence: 99%

Findings and Implications of the Global Burden of Disease 2010 Study for the Pacific Islands

Hoy¹,

Roth²,

Viney³

et al. 2014

Prev. Chronic Dis.

View full text Add to dashboard Cite

The Global Burden of Disease 2010 Study is the largest study of its kind. It provides a large volume of information about the global burden of disease and associated risk factors. It estimates that lower respiratory infections, diabetes, diarrhea, and tuberculosis cause the greatest burden in the Pacific, and noncommunicable diseases caused a substantially greater burden in 2010 compared with 1990. Although the Pacific is considered to be a region rich in data, very little of these data has been analyzed, synthesized, and made publically available. Consequently, burden estimates for the Pacific are derived from models built with very limited data, and it is difficult to know how accurate they are. Health information in the Pacific needs strengthening, particularly in relation to data collection, analysis, use, and sharing. This will improve the reliability and comparability of burden of disease estimates.

show abstract

Stroke Mortality Variations in South-East Asia: Empirical Evidence from the Field

Abstract: This study highlights the extent of stroke mortality in selected Asian countries, and provides important baseline information to investigate the aetiology of stroke in Asia and design appropriate public health strategies to address the rapidly growing burden from stroke.

Cited by 32 publications

References 30 publications

Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages

Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages

How is Indonesia coping with its epidemic of chronic noncommunicable diseases? A systematic review with meta-analysis

Findings and Implications of the Global Burden of Disease 2010 Study for the Pacific Islands

Contact Info

Product

Resources

About